MEHTA; Jodhbir Singh
Patent Applications and Registrations
Patent applications and USPTO patent grants for MEHTA; Jodhbir Singh.The latest application filed is for "use of an osmolyte in manufacture of a medicament for treatment of ocular disorders".
- MEHTA; Jodhbir Singh - Singapore SG
| Patent | Date |
|---|---|
| Use Of An Osmolyte In Manufacture Of A Medicament For Treatment Of Ocular Disorders App 20220265591 - MEHTA; Jodhbir Singh ; et al. | 2022-08-25 |
| Enrichment and characterization of human corneal endothelial cells (hCENC) with novel monoclonal antibody Grant 10,287,547 - Ding , et al. | 2019-05-14 |
| Nanoliposomes For Sustained Delivery Of Tacrolimus For Treatment Of Anterior Segment Eye Diseases App 20190117631 - VENKATRAMAN; Subramanian ; et al. | 2019-04-25 |
| Enrichment And Characterization Of Human Corneal Endothelial Cells (hcenc) With Novel Monoclonal Antibody App 20170037366 - DING; Mei Yee Vanessa ; et al. | 2017-02-09 |
| Corneal graft evaluation based on optical coherence tomography image Grant 8,958,621 - Lee , et al. February 17, 2 | 2015-02-17 |
| Corneal Graft Evaluation Based On Optical Coherence Tomography Image App 20130251230 - Lee; Beng Hai ; et al. | 2013-09-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 